A Look Inside NAS Election Process

WASHINGTON—The recent controversy over the rejection of Harvard political scientist Samuel Huntington for membership in the National Academy of Sciences, which spilled over into a rare public debate, has focused attention on the academy's election process. It's an elaborate procedure, deliberately shrouded in secrecy, that repeatedly screens out candidates until a consensus emerges on those most worthy of NAS membership. it is built around a system that divides all of science into five cl

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It's an elaborate procedure, deliberately shrouded in secrecy, that repeatedly screens out candidates until a consensus emerges on those most worthy of NAS membership. it is built around a system that divides all of science into five classes, each of which receives a share (called a quota) of the 60 member slots that can be filled each year. (Non-U.S. citizens may be elected as foreign associates.)

The quotas are set by the Council, a 17-person policy-making body that meets six times a year. Although several present and former councilors admitted that the quota system is not entirely rational, many are reluctant to discuss a process that has set them above their colleagues. The academy's bylaws say the actual quotas shall remain "strictly confidential."

Currently president of the American Political Science Association, Huntington was voted down for the second year in a row after an unusually visible and heated campaign. Critics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies